Pivotal work by Fuster et al. in atherosclerosis-prone, low-density lipoprotein receptor–deficient (LDLR-deficient) mice whose bone marrow was reconstituted with Tet2-deficient cells showed a significant increase in atherosclerotic plaque size relative to wild-type control mice (9). This evidence concerns the gene TET2 and atherosclerosis.